Skip to main content
. 2022 Jan 24;8:797890. doi: 10.3389/fmed.2021.797890

Figure 5.

Figure 5

Forest plots depicting the SMD of MASI reduction in patients with melasma receiving botanical products in active-controlled trials. Subgroup analysis was stratified according to the duration of the intervention.